Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Patent Foramen Ovale: full-pipeline trial registry

2 of 8 indexed Patent Foramen Ovale trials are currently recruiting.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Patent Foramen Ovale: 8 US clinical trials tracked, 2 recruiting.

Patent Foramen Ovale is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Oregon, running 2 of these trials.

Enrollment posture brief

Registry condition patent-foramen-ovale

OPEN 2 | RECR 25% | LATE 1 | EARLY 1 | RANK #2176 | SPON 2

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Patent Foramen Ovale (this)25%
Open-enrollment share among volume-matched conditions near Patent Foramen Ovale

Patent Foramen Ovale lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Patent Foramen Ovale on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Patent Foramen Ovale is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Patent Foramen Ovale research.

    University of Oregon accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Patent Foramen Ovale enrolment sits around 450 participants.

    Median target enrolment is 450 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Patent Foramen Ovale research is mostly interventional.

    6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Named interventions

Most-linked intervention names on Patent Foramen Ovale records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Standard of Care PFO Closure Device Device
1 trials
Investigational PFO Closure Device Device
1 trials
AMPLATZER™ PFO Occluder Device
1 trials
Sildenafil Drug
1 trials
Recross P3 Occluder (P3O) System Device
1 trials
Warfarin Drug
1 trials
FDA-approved PFO closure device Device
1 trials
Encore PFO closure device Device
1 trials

US sites by state

Facility locations filed on Patent Foramen Ovale trials. A trial with sites in several states counts in each.

California 4 trials
South Carolina 2 trials
Oregon 2 trials
New York 2 trials
Nebraska 2 trials
Massachusetts 2 trials
Florida 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Patent Foramen Ovale page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Patent Foramen Ovale condition card totals 8 registered trials; most-linked intervention Standard of Care PFO Closure Device; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.